Strontium compound for treatment of sub-dermal soft tissue pain

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9050312
APP PUB NO 20110038953A1
SERIAL NO

12913508

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides a method of treatment of a human or non-human subject to combat sub-dermal soft tissue pain therein, said method comprising administering to a subject in need thereof an effective amount of a physiologically tolerable strontium compound.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANA PHARMA MEDICAL ASENEBAKKVEIEN 117A OSLO 0680

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fagerlund, Bjørn Jarl Oslo, NO 1 0
Jellum, Egil Oslo, NO 5 15
Kjølberg, Clas Magne Oslo, NO 1 0
Klaveness, Jo Oslo, NO 187 4245

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 9, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00